SCHEMBL5222900

SCHEMBL5222900

CCCc1cc(C(=O)O)c(F)c(N2CCCS2(=O)=O)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSD P07339 4/20 0.37
BACE1 P56817 4/20 0.37
BACE2 Q9Y5Z0 4/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
PARP1 P09874 2/20 0.36
POLB P06746 1/20 0.36
TP53 P04637 3/20 0.35
MCL1 Q07820 1/20 0.35
PIK3C3 Q8NEB9 2/20 0.35
RARB P10826 2/20 0.33
RARA P10276 1/20 0.33
RARG P13631 1/20 0.33
CDK1 P06493 1/20 0.32
CDK4 P11802 1/20 0.32
CDK2 P24941 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5218901 0.96 BACE1 (0.40) CTSDBACE1BACE2CYP3A4CYP2D6
SCHEMBL5221011 0.87 CTSD (0.39) CTSDBACE1BACE2CYP3A4CYP2D6
SCHEMBL5218910 0.85 MCL1 (0.34) CTSDBACE1BACE2CYP3A4CYP2D6
SCHEMBL5223859 0.84 CTSD (0.42) CTSDBACE1BACE2CYP3A4CYP2D6
SCHEMBL5223174 0.82 BACE1 (0.49) CTSDBACE1BACE2CYP3A4CYP2D6
SCHEMBL5220634 0.79 BACE1 (0.52) CTSDBACE1BACE2CYP3A4CYP2D6
SCHEMBL5221024 0.77 PIK3C3 (0.35) POLBTP53PIK3C3MAPT
SCHEMBL5221777 0.76 ALDH1A1 (0.40) BACE1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5221196 0.73 CTSD (0.42) CTSDBACE1BACE2CYP3A4CYP2D6
SCHEMBL5223868 0.73 CTSD (0.34) CTSDBACE1BACE2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed